AlphaGen
Access AlphaGen
Company Narratives

ZIL Limited H1 2026: Revenue Growth Survives, but Q2 Margin Compression Erases Earnings

ZIL grew H1 2026 sales, but cost pressure intensified in Q2, compressing margins, turning profit into loss and stretching working capital.

Sep 19, 2026

Company Name: ZIL Ltd

Ticker: ZIL

Reporting period: six months ended 30 June 2026. Primary analytical basis: ZIL Limited’s company-level condensed interim financial statements. The cumulative six-month statements were subject to a limited review by BDO Ebrahim & Co. under ISRE 2410; the separately presented three-month Q2 figures were not reviewed. Amounts in the financial statements are presented in Pakistani rupees, principally Rs ‘000.

Verdict

ZIL’s H1 2026 result is a case of resilient revenue but sharply weaker earnings quality. Net sales rose 8.1% year on year to Rs3.44 billion, yet gross profit slipped 1.1% and operating profit fell 53.4% to Rs65.8 million. The key economic change was cost pressure: raw and packing materials consumed increased faster than sales, while selling and distribution spending also rose. The pressure became much more visible in Q2, when net sales were almost flat but gross margin contracted by about 383 basis points and the company moved from a Rs30.7 million quarterly profit to a Rs47.1 million loss.

The result is not best described as a demand collapse. Gross sales still grew 9% in the half, and management said the business maintained growth despite competitive conditions and strained consumer demand. The problem was that the cost of delivering that growth rose faster than revenue. Management specifically linked the squeeze to geopolitical instability, higher commodity and raw-material prices, supply-chain disruption and higher logistics costs. The balance sheet also shows a substantial working-capital build in inventory and receivables, largely financed by a rise in trade and other payables.

Results at a glance

  • Net sales increased 8.1% to Rs3.442 billion from Rs3.183 billion; gross sales rose 9.1% to Rs4.917 billion.
  • Gross profit declined 1.1% to Rs1.013 billion, taking gross margin to 29.45% from 32.21%, a contraction of about 276 basis points.
  • Selling and distribution expense increased 13.0% to Rs750.8 million, while administrative expense declined 7.7% to Rs219.6 million.
  • Operating profit fell 53.4% to Rs65.8 million, and operating margin compressed to 1.91% from 4.44%.
  • Finance charges declined 30.7% to Rs33.1 million, but this relief was not enough to offset weaker operating profitability.
  • Profit before levy and tax fell to Rs7.2 million from Rs66.8 million. A Rs35.2 million minimum-tax levy then pushed the company to a Rs28.0 million loss before income tax.
  • Profit after tax swung to a Rs45.7 million loss from a Rs31.8 million profit; H1 EPS moved to a loss of Rs7.47 from earnings of Rs5.19.
  • Net cash generated from operations increased to Rs228.3 million from Rs142.6 million, but the headline improvement was helped by lower tax and finance payments and a large rise in payables.

AlphaGen model readings

  • Alpha QoQ Score: 20.10
  • TTM Performance Score: 7.66
  • 3Y Business Perf Score: 55.26
  • Sector Leadership Score: 12.95

These four readings are AlphaGen model outputs, not company-reported figures.

What improved

The top line remained positive. H1 net sales grew by roughly Rs258 million and gross sales by about Rs409 million. That matters because the company was operating in a difficult consumer environment rather than simply shrinking its way through cost pressure. Management’s own review describes the market as competitive and consumer demand as strained, yet gross sales still advanced.

Finance charges were another clear positive. They fell to Rs33.1 million from Rs47.8 million, a reduction of about Rs14.7 million. The company also generated Rs22.7 million of other income versus Rs18.2 million a year earlier. Note disclosures show Rs20.8 million of rental income from related parties during the half, indicating that property-related income remained a meaningful, recurring but non-core contributor rather than an exceptional gain.

Liquidity indicators improved modestly on a static basis. Current assets rose to Rs1.849 billion from Rs1.297 billion at December 2025, while current liabilities rose to Rs1.904 billion from Rs1.387 billion. The current ratio therefore improved to about 0.97x from 0.94x and the working-capital deficit narrowed to roughly Rs54.9 million from Rs89.8 million. Cash and bank balances more than doubled to Rs421.5 million.

What weakened / needs attention

The central weakness is margin compression. Cost of sales rose 12.5% in H1, faster than the 8.1% increase in net sales. Raw and packing materials consumed increased 10.9% to Rs2.316 billion. The gross-margin loss of roughly 276 basis points then flowed into operating profitability, where higher selling and distribution expense added another layer of pressure.

The second weakness is the deterioration inside the half. Q1 had been much stronger: official first-quarter statements showed net sales of about Rs1.447 billion, up roughly 19.7% year on year, with a small profit after tax. By contrast, Q2 net sales rose only 1.0% to Rs1.994 billion. Q2 gross profit fell 10.9% to Rs567.6 million and operating profit collapsed to Rs9.4 million from Rs92.2 million. The company then reported a Rs47.1 million Q2 net loss versus a Rs30.7 million profit a year earlier.

The Q2 cost bridge is especially important. Raw and packing materials consumed in Q2 rose about 31.4% year on year to Rs1.337 billion even though net sales grew only about 1%. That mismatch is the clearest numerical expression of the cost shock described by management. It also means the H1 revenue-growth headline overstates the current run-rate because most of the sales growth was generated in Q1.

Why profitability changed economically

Management attributes the pressure to global conflict, higher commodity and raw-material prices, logistics disruption and supply-chain imbalances. Those explanations are directionally consistent with the accounts: material consumption rose faster than sales, especially in Q2, while gross margin fell sharply. They should still be treated as management’s explanation rather than as proof that every point of margin contraction came from external factors.

Independent macro evidence supports the existence of a difficult input and pricing environment. The State Bank of Pakistan noted in its January 2026 monetary-policy minutes that global oil, metal and agricultural commodity prices had risen by more than 3% since the previous meeting amid geopolitical developments. Pakistan Bureau of Statistics later reported June 2026 CPI inflation of 11.07% year on year and average FY2026 inflation of 7.05%. This backdrop is consistent with pressure on both household purchasing power and imported or commodity-linked input costs, but it does not by itself establish ZIL’s product volumes or price elasticity.

A peer check also argues against reducing the entire story to broad sector weakness. Colgate-Palmolive Pakistan’s official FY2026 data show sales growth of roughly 8% with a broadly stable gross margin. The reporting periods are not directly comparable—Colgate’s figures cover a full fiscal year while ZIL’s result is a six-month period—but the comparison is still useful as a boundary condition: revenue growth in the broader household and personal-care space did not automatically require the degree of gross-margin compression seen at ZIL. Product mix, sourcing, pricing timing and company-specific execution could therefore matter, although the public ZIL filing does not quantify their individual effects.

Cash flow: better headline, mixed quality

Operating cash flow rose 60.1% to Rs228.3 million, which at first glance appears much stronger than the income statement. The reconciliation shows why the quality of that improvement needs qualification. Cash generated before working-capital changes fell to Rs149.3 million from Rs247.5 million, consistent with weaker underlying earnings. Inventory absorbed about Rs195.2 million and trade debts another Rs139.8 million.

Those uses of cash were more than offset by a Rs583.8 million increase in trade and other payables. Contract liabilities also fell by Rs77.2 million. After working-capital movements, cash generated from operations was Rs310.5 million, slightly below the prior-year Rs319.8 million. The final reported operating-cash-flow improvement mainly reflects lower tax payments—Rs37.9 million versus Rs139.3 million—and lower finance-cost payments of Rs17.9 million versus Rs35.3 million.

This does not make the cash flow weak, but it changes the interpretation. ZIL finished the half with far more cash, yet part of that liquidity came from supplier and payable financing rather than from stronger pre-working-capital cash earnings. For the next cycle, the key test is whether the inventory and receivable build converts to sales and collections without requiring another large expansion in payables.

Balance sheet and funding

Inventory rose 27.5% from December to Rs904.5 million, while trade debts nearly doubled to Rs288.5 million. Together they increased by about Rs335 million in six months. Trade and other payables rose 51.8% to Rs1.721 billion, including trade creditors of Rs1.241 billion compared with Rs702.9 million at December. This is the most important working-capital movement on the balance sheet.

Long-term financing also increased. The non-current portion of the company’s diminishing Musharaka facility rose to Rs47.1 million from Rs10.2 million, with another Rs8.6 million classified as current maturity. Short-term related-party borrowing remained Rs31.8 million and is disclosed as interest-free and immediately payable, subject to State Bank approval for repatriation. Total equity declined 4.4% to Rs1.334 billion after the half-year loss and the payment of the prior-year dividend.

The balance sheet therefore remains solvent on an equity basis, but short-term liquidity is tight: current liabilities still exceed current assets. The higher cash balance is useful, yet it should be viewed alongside the larger inventory, receivable and payable positions rather than in isolation.

Recurring versus less-repeatable earnings drivers

There is no large disposal gain or obvious one-off windfall driving H1 earnings. The result is instead dominated by recurring operating lines: sales, raw and packing materials, distribution spending, finance charges and the statutory tax/levy structure. Other income is modest but meaningful; related-party rental income of Rs20.8 million appears recurring and economically separate from the core home and personal-care business.

The Rs35.2 million levy deserves separate treatment. The notes identify it as minimum tax under section 113 and classify it as a levy. It turned a small Rs7.2 million profit before levy and tax into a Rs28.0 million loss before income tax. It should not be treated as an unusual operating expense, but neither is it a pure one-time item: while taxable minimum-tax conditions persist, this statutory burden can recur even when accounting profitability is weak.

The H1 dividend cash outflow of about Rs15.2 million relates to the prior year’s approved Rs2.50-per-share dividend. It is a capital-allocation item, not a cost of producing the current half-year result.

What changed versus the recent pattern

The first quarter suggested ZIL was still extending the 2025 revenue recovery: sales grew strongly and profitability remained around breakeven. Q2 changed that interpretation. Sales momentum slowed dramatically while material consumption accelerated, turning a small first-quarter profit into a substantial quarterly loss. The half-year outcome is therefore less about the average H1 growth rate and more about a deterioration in the most recent three months.

Historically, ZIL has demonstrated that margins can recover sharply when gross economics normalize: full-year 2025 gross margin was materially stronger than several earlier years. H1 2026 does not erase that progress, but it shows the recovery is vulnerable to input-cost shocks and to the company’s ability to pass those costs through prices without damaging demand.

What to monitor next

  • Q3 gross margin and raw-material consumption: the clearest sign of stabilization would be material-cost growth returning closer to sales growth.
  • Pricing versus volume: management says pricing adjustments may be needed. The next report should be checked for whether sales growth comes from price, volume or mix, if disclosed.
  • Inventory and receivables: the combined build was substantial. Conversion into sales and cash matters more than the period-end cash balance alone.
  • Trade and other payables: another large increase could support cash temporarily but would weaken the quality of cash conversion.
  • Minimum-tax levy: monitor whether the section 113 burden remains material if accounting profitability stays low.
  • Finance cost and new financing: lower H1 finance charges were helpful, but the Musharaka balance increased and should be monitored alongside repayment obligations.
  • Consumer and input-cost environment: inflation, commodity prices and logistics conditions remain relevant to both pricing power and gross margin.

Bottom line

ZIL’s H1 2026 result shows that revenue resilience alone was not enough to preserve earnings. The company grew net sales by 8%, but gross margin contracted, distribution spending rose and the business moved into loss. The most important development was the Q2 deterioration: near-flat sales collided with a sharp rise in raw and packing material consumption, wiping out most operating profit. Cash generation improved on the surface, but lower tax and finance payments and a large payable build explain much of the difference. The next result cycle will be judged on whether ZIL can restore gross margin, convert working capital and prevent Q2’s cost-to-sales mismatch from becoming the new normal.

Sources

Explore more research

All articles